Segment-and-Classify: ROI-Guided Generalizable Contrast Phase Classification in CT Using XGBoost

Abstract

Purpose: To automate contrast phase classification in CT using organ-specific features extracted from a widely used segmentation tool with a lightweight decision tree classifier. Materials and Methods: This retrospective study utilized three public CT datasets from separate institutions. The phase prediction model was trained on the WAW-TACE (median age: 66 [60,73]; 185 males) dataset, and externally validated on the VinDr-Multiphase (146 males; 63 females; 56 unk) and C4KC-KiTS (median age: 61 [50.68; 123 males) datasets. Contrast phase classification was performed using organ-specific features extracted by TotalSegmentator, followed by prediction using a gradient-boosted decision tree classifier. Results: On the VinDr-Multiphase dataset, the phase prediction model achieved the highest or comparable AUCs across all phases (>0.937), with superior F1-scores in the non-contrast (0.994), arterial (0.937), and delayed (0.718) phases. Statistical testing indicated significant performance differences only in the arterial and delayed phases (p<0.05). On the C4KC-KiTS dataset, the phase prediction model achieved the highest AUCs across all phases (>0.991), with superior F1-scores in arterial/venous (0.968) and delayed (0.935) phases. Statistical testing confirmed significant improvements over all baseline models in these two phases (p<0.05). Performance in the non-contrast class, however, was comparable across all models, with no statistically significant differences observed (p>0.05). Conclusion: The lightweight model demonstrated strong performance relative to all baseline models, and exhibited robust generalizability across datasets from different institutions.

0

Turn this paper into a full lesson

ArcXiv compiles a staged curriculum from this paper: 8-12 lessons across beginner → advanced, synthesised section guides, visuals, flashcards, a quiz, exercises, and on-demand deep dives per section. Grounded in the abstract, never invented.

Discussion (0)

Sign in to join the discussion.

Loading comments…